To include your compound in the COVID-19 Resource Center, submit it here.

Surfaxin lucinactant: Began Phase III study

Discovery Laboratories Inc. (DSCO), Doylestown, Penn.
Product: Surfaxin

Read the full 84 word article

Trial Subscription

Get a two-week free trial subscription to BioCentury

SIGN UP

Article Purchase

This article may not be distributed to non-subscribers
More Info >PURCHASE